REVB - Dow Jumps 250 Points; Honeywell Issues Weak Forecast | Benzinga
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 250 points on Thursday.
The Dow traded up 0.66% to 38,403.91 while the NASDAQ rose 1.01% to 15,316.80. The S&P 500 also rose, gaining, 0.87% to 4,887.70.
Check This Out: $320M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
Leading and Lagging Sectors
Consumer staples shares rose by 1.6% on Thursday.
In trading on Thursday, energy shares fell by 0.2%.
Top Headline
Honeywell International Inc (NASDAQ: HON) reported downbeat revenue for its fourth quarter and issued weak outlook.
Honeywell reported fourth-quarter fiscal 2023 sales of $9.44 billion, up 3% year-over-year on a reported basis and +2% on an organic basis, missing the consensus of $9.70 billion. Adjusted EPS was $2.60 (+3% Y/Y), beating the consensus of $2.59.
For the first quarter, Honeywell sees adjusted EPS of $2.12-$2.22 (consensus $2.24) and sales of $8.9 billion-$9.2 billion (consensus $9.248 billion).
Equities Trading UP
Cimpress plc (NASDAQ: CMPR) shares shot up 23% to $92.54 after the company reported better-than-expected second-quarter financial results and said the board authorized the repurchase of up to $150 million of company shares.
Shares of NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) got a boost, surging 72% to $5.61 after the company announced FDA clearance of the IND for a Phase 1 clinical trial of DA-1726 ...